CIDINITAB M 50 and CIDINITAB M 25 are powerful combination medications used to manage hypertension and certain heart conditions. They combine the benefits of Cilnidipine, a calcium channel blocker, and Metoprolol, a beta-blocker, to provide effective control over blood pressure and improve cardiovascular health.

Key Features:

• Dual Action: CIDINITAB M 50 and CIDINITAB M 25 work synergistically to regulate blood pressure by dilating blood vessels (Cilnidipine) and reducing heart rate and workload (Metoprolol).
• Customized Strengths: CIDINITAB M 50 contains 50 mg of Cilnidipine and 25 mg of Metoprolol, while CIDINITAB M 25 contains 25 mg of Cilnidipine and 25 mg of Metoprolol, allowing for tailored treatment based on individual needs.
• Long-lasting Effectiveness: These medications provide sustained blood pressure control, helping to prevent complications associated with hypertension and cardiovascular disorders.
• Well-Tolerated: CIDINITAB M 50 and CIDINITAB M 25 are generally well-tolerated, with minimal side effects such as dizziness or fatigue, which usually subside with continued use.
• Patient Compliance: The convenient once-daily dosing of CIDINITAB M 50 and CIDINITAB M 25 enhances patient compliance, ensuring consistent therapy and better health outcomes.

How to Use:

• Follow your healthcare provider's instructions regarding dosage and administration.
• Take CIDINITAB M 50 or CIDINITAB M 25 regularly at the same time each day, with or without food.
• Do not stop taking the medication abruptly without consulting your doctor, as it may lead to rebound effects.

Precautions:

• Inform your doctor about any existing medical conditions or medications before starting CIDINITAB M 50 or CIDINITAB M 25.
• Avoid alcohol consumption while on these medications, as it may potentiate certain side effects.
• Monitor your blood pressure regularly and report any unusual symptoms to your healthcare provider promptly.

Conclusion:

CIDINITAB M 50 and CIDINITAB M 25 offer a comprehensive approach to blood pressure management, combining the efficacy of Cilnidipine and Metoprolol in convenient dosage forms. Consult your healthcare provider to see if CIDINITAB M 50 or CIDINITAB M 25 is suitable for your cardiovascular health needs.A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668    BUY NOW